Conversely, verapamil inhibits tumor growth by modulating NFAT2 expression and enhancing the immune response to PD-1 antibodies, making it a viable treatment option for cervical cancer, particularly in patients with hypertension (40). The gene discussed is NFATC1; the disease is cervical carcinoma.